• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估奥地利南部呼吸道合胞病毒住院的经济和流行病学影响[奥地利南部呼吸道合胞病毒住院调查(ARNI 研究)]。

Evaluating the Economic and Epidemiological Impact of RSV Hospitalizations in Southern Austria [Southern Austria Respiratory Syncytial Virus INpatient Investigation (ARNI Study)].

机构信息

Research Unit for Neonatal Infectious Diseases and Epidemiology, Medical University of Graz, Graz, Austria.

Department of Paediatrics and Adolescent Medicine, Division of General Paediatrics, Medical University of Graz, Graz, Austria.

出版信息

Influenza Other Respir Viruses. 2024 Nov;18(11):e70046. doi: 10.1111/irv.70046.

DOI:10.1111/irv.70046
PMID:39537554
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11560340/
Abstract

OBJECTIVE

RSV bronchiolitis is a leading cause of hospitalization in infants and young children. We aimed to document the economic burden and epidemiology of RSV over seven seasons in Southern Austria.

PATIENTS AND METHODS

All RSV-associated hospitalized (PCR-proven) children ≤ 5 years of age between 1 October 2015 and 30 April 2022 were collected retrospectively. Demographic and epidemiologic data, along with hospitalization costs (direct and indirect), were calculated.

RESULTS

Among 976 children hospitalized due to RSV infection, 87% were healthy term infants, and 79% were < 12 months old. Prematurity (13%) and pre-existing conditions (11%) significantly impacted older children-59% of cases in the 2nd compared with 68% in the 1st year of live. RSV-related hospital costs were approximately €2.0 millions per year (of a total of 60 millions per year). RSV accounted for 19% of hospitalizations due to acute respiratory illness (ARI) in children ≤ 5 years, 37% of all ARI < 6 months, 28% of all ARI < 12 and 6.3% of all-cause hospitalizations < 12 months of age, respectively.

CONCLUSIONS

Every 5th hospitalization due to respiratory illness in children ≤ 5 years of age was associated with RSV, representing 7.9% of all hospitalizations and 3.3% of all paediatric hospitalization costs.

摘要

目的

呼吸道合胞病毒(RSV)毛细支气管炎是导致婴儿和幼儿住院的主要原因。本研究旨在记录奥地利南部七个流行季节 RSV 的经济负担和流行病学情况。

患者和方法

回顾性收集了 2015 年 10 月 1 日至 2022 年 4 月 30 日期间因呼吸道合胞病毒(PCR 证实)住院的所有≤5 岁的患儿的人口统计学和流行病学数据,以及住院费用(直接和间接)。

结果

在因 RSV 感染住院的 976 名儿童中,87%为健康足月婴儿,79%年龄<12 个月。早产(13%)和基础疾病(11%)显著影响大龄儿童,与 1 岁组相比,2 岁组中分别有 59%和 68%的病例存在上述情况。与 RSV 相关的住院费用约为每年 200 万欧元(每年 6000 万欧元总费用的一部分)。RSV 占≤5 岁儿童因急性呼吸道感染(ARI)住院的 19%,占所有<6 个月 ARI 的 37%,占所有<12 个月 ARI 的 28%,占所有<12 个月儿童住院的 6.3%。

结论

在≤5 岁儿童因呼吸道疾病住院的患儿中,每 5 例中就有 1 例与 RSV 相关,占所有住院的 7.9%,占所有儿科住院费用的 3.3%。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/570e/11560340/f26acf6abff7/IRV-18-e70046-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/570e/11560340/a84ca4099d1a/IRV-18-e70046-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/570e/11560340/f26acf6abff7/IRV-18-e70046-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/570e/11560340/a84ca4099d1a/IRV-18-e70046-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/570e/11560340/f26acf6abff7/IRV-18-e70046-g001.jpg

相似文献

1
Evaluating the Economic and Epidemiological Impact of RSV Hospitalizations in Southern Austria [Southern Austria Respiratory Syncytial Virus INpatient Investigation (ARNI Study)].评估奥地利南部呼吸道合胞病毒住院的经济和流行病学影响[奥地利南部呼吸道合胞病毒住院调查(ARNI 研究)]。
Influenza Other Respir Viruses. 2024 Nov;18(11):e70046. doi: 10.1111/irv.70046.
2
Economic and disease burden of RSV-associated hospitalizations in young children in France, from 2010 through 2018.2010 年至 2018 年法国与呼吸道合胞病毒相关的幼儿住院的经济和疾病负担。
BMC Infect Dis. 2021 Aug 2;21(1):730. doi: 10.1186/s12879-021-06399-8.
3
Economic burden of children hospitalized with respiratory syncytial virus infection in Spain, 2016-2019.2016 - 2019年西班牙呼吸道合胞病毒感染住院儿童的经济负担
Vaccine. 2025 Jan 1;43(Pt 2):126512. doi: 10.1016/j.vaccine.2024.126512. Epub 2024 Nov 7.
4
Burden of respiratory syncytial virus (RSV) infection in Germany: a systematic review.德国呼吸道合胞病毒(RSV)感染负担:系统评价。
BMC Infect Dis. 2024 Aug 20;24(1):844. doi: 10.1186/s12879-024-09758-3.
5
Epidemiology of Respiratory Syncytial Virus-related Hospitalizations and the Influence of Viral Coinfections in Southern Austria in a 7-year Period.呼吸道合胞病毒相关住院患者的流行病学及 7 年间在奥地利南部病毒混合感染的影响
Pediatr Infect Dis J. 2020 Jan;39(1):12-16. doi: 10.1097/INF.0000000000002494.
6
Respiratory syncytial virus hospitalization outcomes and costs of full-term and preterm infants.呼吸道合胞病毒感染对足月儿和早产儿住院治疗的结局及费用影响
J Perinatol. 2016 Nov;36(11):990-996. doi: 10.1038/jp.2016.113. Epub 2016 Aug 4.
7
The cost of care for children hospitalized with respiratory syncytial virus (RSV) associated lower respiratory infection in Kenya.肯尼亚因呼吸道合胞病毒(RSV)相关下呼吸道感染而住院的儿童的护理成本。
BMC Public Health. 2024 Sep 4;24(1):2410. doi: 10.1186/s12889-024-19875-y.
8
Respiratory syncytial virus-associated hospitalizations among children: an Italian retrospective observational study.呼吸道合胞病毒相关儿童住院治疗:意大利回顾性观察研究。
Ital J Pediatr. 2024 Mar 7;50(1):45. doi: 10.1186/s13052-024-01617-w.
9
Description of the outcomes of prior authorization of palivizumab for prevention of respiratory syncytial virus infection in a managed care organization.在一家管理式医疗组织中,帕利珠单抗预防呼吸道合胞病毒感染的预先授权结果描述。
J Manag Care Pharm. 2010 Jan-Feb;16(1):15-22. doi: 10.18553/jmcp.2010.16.1.15.
10
Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age.小于 24 月龄儿童因呼吸道合胞病毒导致的住院治疗。
Pediatrics. 2013 Aug;132(2):e341-8. doi: 10.1542/peds.2013-0303. Epub 2013 Jul 22.

引用本文的文献

1
Respiratory syncytial virus hospitalization costs, rates, and seasonality in Asia: a systematic review and meta-analysis.亚洲呼吸道合胞病毒住院费用、发生率及季节性:一项系统评价与荟萃分析
EClinicalMedicine. 2025 Jul 10;86:103350. doi: 10.1016/j.eclinm.2025.103350. eCollection 2025 Aug.
2
RSV Hospital Admissions During the First 2 Seasons Among Children With Chronic Medical Conditions.在最初两个季节中,患有慢性疾病儿童的呼吸道合胞病毒住院情况。
JAMA Netw Open. 2025 Jul 1;8(7):e2519410. doi: 10.1001/jamanetworkopen.2025.19410.
3
Laboratory-confirmed respiratory syncytial virus (RSV) hospitalizations: a national all ages cross-section evaluation, 2020-2024.

本文引用的文献

1
Burden of Respiratory Syncytial Virus in the European Union: estimation of RSV-associated hospitalizations in children under 5 years.欧盟呼吸道合胞病毒负担:5岁以下儿童呼吸道合胞病毒相关住院病例数估计
J Infect Dis. 2023 Nov 28;228(11):1528-1538. doi: 10.1093/infdis/jiad188.
2
The economic burden of RSV-associated illness in children aged < 5 years, South Africa 2011-2016.2011-2016 年南非 < 5 岁儿童呼吸道合胞病毒相关疾病的经济负担。
BMC Med. 2023 Apr 13;21(1):146. doi: 10.1186/s12916-023-02854-2.
3
Economic burden and health-related quality-of-life among infants with respiratory syncytial virus infection: A multi-country prospective cohort study in Europe.
实验室确诊的呼吸道合胞病毒(RSV)住院病例:2020 - 2024年全国全年龄段横断面评估
Isr J Health Policy Res. 2025 Jun 11;14(1):36. doi: 10.1186/s13584-025-00693-5.
呼吸道合胞病毒感染婴儿的经济负担及与健康相关的生活质量:欧洲一项多国前瞻性队列研究
Vaccine. 2023 Apr 17;41(16):2707-2715. doi: 10.1016/j.vaccine.2023.03.024. Epub 2023 Mar 21.
4
The Long-Term Healthcare Utilization and Economic Burden of RSV Infection in Children ≤5 Years in Japan: Propensity Score Matched Cohort Study.日本5岁及以下儿童呼吸道合胞病毒感染的长期医疗利用情况及经济负担:倾向评分匹配队列研究
Clinicoecon Outcomes Res. 2022 Nov 9;14:699-714. doi: 10.2147/CEOR.S382495. eCollection 2022.
5
Bronchiolitis therapies and misadventures.毛细支气管炎的治疗和失误。
Paediatr Respir Rev. 2023 Jun;46:49-56. doi: 10.1016/j.prrv.2022.09.003. Epub 2022 Sep 29.
6
Clinical and economic burden of respiratory syncytial virus in Spanish children: the BARI study.西班牙儿童呼吸道合胞病毒的临床和经济负担:BARI 研究。
BMC Infect Dis. 2022 Sep 29;22(1):759. doi: 10.1186/s12879-022-07745-0.
7
Expected Impact of Universal Immunization With Nirsevimab Against RSV-Related Outcomes and Costs Among All US Infants in Their First RSV Season: A Static Model.普遍接种尼赛珠单抗对所有美国婴儿首个呼吸道合胞病毒季节相关结局和成本的预期影响:静态模型。
J Infect Dis. 2022 Aug 15;226(Suppl 2):S282-S292. doi: 10.1093/infdis/jiac216.
8
Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis.2019 年全球、区域和国家因呼吸道合胞病毒导致 5 岁以下儿童急性下呼吸道感染的疾病负担估计:系统分析。
Lancet. 2022 May 28;399(10340):2047-2064. doi: 10.1016/S0140-6736(22)00478-0. Epub 2022 May 19.
9
RSV Prevention in All Infants: Which Is the Most Preferable Strategy?所有婴儿的 RSV 预防:哪种策略最可取?
Front Immunol. 2022 Apr 28;13:880368. doi: 10.3389/fimmu.2022.880368. eCollection 2022.
10
Describing global pediatric RSV disease at intensive care units in GAVI-eligible countries using molecular point-of-care diagnostics: the RSV GOLD-III study protocol.采用分子即时检测技术在符合 Gavi 条件国家的重症监护病房描述全球儿科呼吸道合胞病毒疾病:RSV GOLD-III 研究方案。
BMC Infect Dis. 2021 Aug 23;21(1):857. doi: 10.1186/s12879-021-06544-3.